virus

U of M COVID-19 Clinical Trial Expands Participant Enrollment Opportunities

April 1, 2020

This trial is testing hydroxychloroquine, an FDA-approved medicine for the prevention and treatment of malaria. This is the first clinical trial to determine if hydroxychloroquine is effective in preventing COVID-19 in humans.

Other News

SeroNet COVID-19 Vaccine Response Study screenshot
The University of Minnesota is leading a research study that aims to better understand the immune system’s response to COVID-19 vaccines.…
Drs. Prasad and Natarajan
With the news of a COVID-19 outbreak in India and the World Health Organization urging countries to address global inequalities in health,…
medical reserve
As the fight against COVID-19 becomes a charge to quickly vaccinate Minnesotans—especially the most vulnerable—there remain key…